Niklas Schäfer Selected Research

Niklas Schäfer Research Topics

Disease

28	Glioblastoma (Glioblastoma Multiforme) 08/2022 - 07/2012
12	Neoplasms (Cancer) 03/2022 - 01/2016
7	Glioma (Gliomas) 11/2022 - 01/2013
6	Brain Neoplasms (Brain Tumor) 03/2022 - 01/2016
3	Hemorrhage 01/2021 - 01/2017
3	Ischemic Stroke 01/2020 - 08/2016
2	Multiple Sclerosis 04/2021 - 03/2016
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 01/2017
2	Stroke (Strokes) 01/2020 - 01/2017
2	Hematoma 01/2020 - 01/2017
2	Cerebral Hemorrhage 01/2020 - 01/2017
2	Lymphoma (Lymphomas) 09/2017 - 12/2012
1	Obesity 08/2022
1	Neoplasm Metastasis (Metastasis) 03/2022
1	Germinoma 02/2022
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2022
1	Meningioma (Meningiomas) 12/2020
1	Iatrogenic Disease 10/2020
1	Polyuria 09/2020
1	Urinary Tract Infections (Urinary Tract Infection) 09/2020
1	Postoperative Hemorrhage 09/2020
1	Disease Progression 01/2019
1	Myofibromatosis 01/2019
1	Atrial Fibrillation 08/2016
1	Hypotrichosis simplex 01/2013

Drug/Important Bio-Agent (IBA)

14	Temozolomide (Temodar)FDA LinkGeneric 11/2022 - 07/2012
8	Lomustine (CCNU)FDA Link 08/2022 - 07/2012
8	Bevacizumab (Avastin)FDA Link 08/2022 - 01/2013
6	Irinotecan (Camptosar)FDA LinkGeneric 08/2022 - 01/2013
5	MethyltransferasesIBA 02/2021 - 10/2016
4	Tyrosine (L-Tyrosine)FDA Link 04/2021 - 01/2016
3	idarucizumabIBA 01/2020 - 08/2016
3	Dabigatran FDA Link 01/2020 - 08/2016
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2022 - 07/2018
2	MicroRNAs (MicroRNA)IBA 02/2022 - 09/2020
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 09/2020
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2017
2	(18F)fluoroethyltyrosineIBA 07/2018 - 03/2016
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 12/2012
1	SteroidsIBA 08/2022
1	Ion Channels (Ion Channel)IBA 02/2021
1	Amino Acids FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	C-Reactive ProteinIBA 12/2020
1	phenyl-2-aminoethyl sulfide (PAES)IBA 10/2020
1	Hormones (Hormone)IBA 09/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020
1	regorafenibIBA 11/2019
1	dimemorfan (AT 17)IBA 10/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2019
1	Drug CombinationsIBA 01/2017
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 10/2016
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 07/2016
1	thiamine triphosphorate (TTP)IBA 01/2016
1	Teniposide (VM 26)FDA Link 01/2014
1	Carmustine (FIVB)FDA Link 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013

Therapy/Procedure

17	Therapeutics 02/2022 - 01/2013
7	Radiotherapy 08/2022 - 01/2014
5	Drug Therapy (Chemotherapy) 11/2022 - 09/2017
3	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2020
3	Chemoradiotherapy 10/2019 - 01/2016
2	Anterior Temporal Lobectomy 04/2021 - 09/2020
1	Erythrocyte Transfusion 04/2022
1	Blood Transfusion (Blood Transfusions) 04/2022
1	Precision Medicine 09/2021
1	Catheters 09/2020
1	Length of Stay 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 12/2012
1	Aftercare (After-Treatment) 07/2012